Bowden R, Van Eeckhoutte H, Chow G, Choudhary G, Kallenbach L, Alegria V, Perciavalle M, Salmon J, Kang J, Mondon M, Vanak J, Ciccone D, Millili P, Onorata M, Plaks V, Merz M. P52 | CILTACABTAGENE AUTOLEUCEL OUT-OF-SPECIFICATION MANUFACTURING OUTCOMES IMPROVE WITH EARLIER LINES OF THERAPY. haematol [Internet]. 2026Apr.15 [cited 2026Sep.27];111(s2). Available from: https://haematologica.org/article/view/haematol.2026.s2.14059